Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Study indicates interleukin-6-dependant pathway dysregulation as a key druggable feature of COVID-19

Researchers identified an interleukin 6 dependent alternative pathway as a therapeutic strategy against coronavirus disease 2019.

30 Mar 2023

From an economic crisis to a global pandemic: how have trends in emotional distress changed between 2009 and 2021?

Researchers investigated global trends in emotional discomfort.

30 Mar 2023

The decision-making process for the launch of trials for COVID-19 repurposed antivirals

Researchers reviewed the decision-making process for performing randomized clinical trials for three drugs under consideration for repurposing for COVID-19 treatment: remdesivir, molnupiravir, and tenofovir disoproxil fumarate.

30 Mar 2023

States try to obscure execution details as drugmakers hinder lethal injection

In 2011, Jeffrey Motts was executed in South Carolina. More than a decade later, the state hasn't carried out another execution because officials have struggled to obtain the drugs needed for lethal injection.

30 Mar 2023

Study finds that current antiviral drugs retain efficacy against newly emerged Omicron subvariants

Researchers assessed the efficacy of antiviral medications against novel Omicron subvariants.

30 Mar 2023

Study finds minimal impact of SARS-CoV-2 genome variability on current diagnostic molecular systems

The authors of a new study under review at the journal Scientific Reports and currently posted to the Research Square preprint* server proposed a novel analysis pipeline to help identify mutations in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcription-polymerase chain reaction (RT-PCR) primer regions.

29 Mar 2023

SARS-CoV-2 infection disrupts the RNA modifications, study reports

Coronavirus disease (COVID-19) hijacks parts of infected cells' vital RNA machinery, thereby blocking important functions in the cells. These damaging changes in the RNA can likely be reversed, potentially leading to new drugs against COVID-19, University of Gothenburg researchers show.

29 Mar 2023

Children with in utero exposure to maternal COVID-19 infection more likely to develop obesity

Children born to mothers who had COVID-19 during pregnancy may be more likely to develop obesity, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

29 Mar 2023

Study links altered gut microbiome to allergies in infants raised under COVID-19 lockdown

A recent study posted to medRxiv* preprint server revealed that gut microbiome predicts atopic outcomes in infants with decreased bacterial exposure.

28 Mar 2023

Newly designed molecule disrupts the infection mechanism of SARS-CoV-2

A team of scientists led by the Department of Energy's Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.

28 Mar 2023

The rise of Candida auris: Understanding its origin and persistence

In a recent study published in the PLOS Pathogens journal, researchers from the University of Texas Health Science Center at San Antonio in the United States (US) explored the existing perspectives on the origination, resistance, and transmission of Candida auris, a human fungal pathogen.

28 Mar 2023

COVID-19 activates endogenous retroviruses within our genome

Researchers assess the impact of SARS-CoV-2 infection on endogenous retroviruses of the LTR69 subfamily.

28 Mar 2023

How do viral infections cause autoimmune diseases?

Researchers describe the pathological mechanisms of virus-induced autoimmune diseases.

28 Mar 2023

Global mapping of bushmeat activity to improve zoonotic spillover surveillance

Researchers use geospatial models based to predict the rural global areas of bushmeat activity.

28 Mar 2023

New molecule slows the effects of one of SARS-CoV-2's more dangerous components

Researchers have designed a molecule that slows the effects of one of SARS-CoV-2's more dangerous components – an enzyme called a protease that cuts off the immune system's communications and helps the virus replicate.

28 Mar 2023

What is the effect of prior BCG vaccination on the immunogenicity and efficacy of subsequent COVID-19 vaccination?

Researchers assessed the impact of BCG vaccination on the protection provided by SARS-CoV-2 vaccination.

28 Mar 2023

Study investigates the antigenic and viral receptor-binding properties of major Omicron BA.2.75 subvariants

Researchers in the US examined the neutralization evasion and receptor affinity properties of SARS-CoV-2 Omicron BA.2.75 sub-variants.

28 Mar 2023

Case report on Nocardia pseudobrasiliensis and SARS-CoV-2 concomitant infection

In a recent case report published in the U.S. Centers for Disease Control and Prevention’s (CDC) journal Emerging Infectious Diseases, researchers reported a case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Nocardia pseudobrasiliensis concomitant infection.

27 Mar 2023

New study suggests broad neutralizing antibody could provide three years of COVID protection

In a recent article published in the journal Science Translational Medicine, researchers showed that a novel, lab-engineered monoclonal antibody (mAb), adintrevimab conferred up to 50% protection against symptomatic coronavirus disease 2019 (COVID-19). Furthermore, it demonstrated this exceptional efficacy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–naïve individuals even at titers as low as 1:30.

27 Mar 2023

How can Europe tackle its unfinished tuberculosis business?

A recent Eurosurveillance journal editorial discussed the progress in the EU/EEA, between 2018 and 2021, towards achieving the 2030 targets for TB elimination.

27 Mar 2023

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Study indicates interleukin-6-dependant pathway dysregulation as a key druggable feature of COVID-19

From an economic crisis to a global pandemic: how have trends in emotional distress changed between 2009 and 2021?

The decision-making process for the launch of trials for COVID-19 repurposed antivirals

States try to obscure execution details as drugmakers hinder lethal injection

Study finds that current antiviral drugs retain efficacy against newly emerged Omicron subvariants

Study finds minimal impact of SARS-CoV-2 genome variability on current diagnostic molecular systems

SARS-CoV-2 infection disrupts the RNA modifications, study reports

Children with in utero exposure to maternal COVID-19 infection more likely to develop obesity

Study links altered gut microbiome to allergies in infants raised under COVID-19 lockdown

Newly designed molecule disrupts the infection mechanism of SARS-CoV-2

The rise of Candida auris: Understanding its origin and persistence

COVID-19 activates endogenous retroviruses within our genome

How do viral infections cause autoimmune diseases?

Global mapping of bushmeat activity to improve zoonotic spillover surveillance

New molecule slows the effects of one of SARS-CoV-2's more dangerous components

What is the effect of prior BCG vaccination on the immunogenicity and efficacy of subsequent COVID-19 vaccination?

Study investigates the antigenic and viral receptor-binding properties of major Omicron BA.2.75 subvariants

Case report on Nocardia pseudobrasiliensis and SARS-CoV-2 concomitant infection

New study suggests broad neutralizing antibody could provide three years of COVID protection

How can Europe tackle its unfinished tuberculosis business?

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in